K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Matthew Meyerson
also known as M Meyerson, M. MEYERSON, M. Meyerson
Broad Institute · BGI Group (China) · Boston University · Ontario Institute for Cancer Research
About this author
Works
1,772
Cited by
293,126
h-index
217
i10
452
ORCID ↗
Top papers
Signatures of mutational processes in human cancer
Australian Pancreatic Cancer Genome Initiative, Ludmil B. Alexandrov, ICGC PedBrain, et al.
·
2013
·
Nature
↗ 10,065
OA
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, et al.
·
2004
·
Science
↗ 9,387
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
·
2012
·
Nature
↗ 8,435
Integrated genomic analyses of ovarian carcinoma
Debra Bell, Andrew Berchuck, Andrew Berchuck, et al.
·
2011
·
Nature
↗ 8,097
OA
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom, et al.
·
2010
·
Cancer Cell
↗ 7,688
OA
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence, Petar Stojanov, Paz Polak, et al.
·
2013
·
Nature
↗ 5,678
OA
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie, Pablo Tamayo, Jesse S. Boehm, et al.
·
2009
·
Nature
↗ 4,152
OA
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim, Craig H. Mermel, Dale Porter, et al.
·
2010
·
Nature
↗ 4,097
OA
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, et al.
·
2005
·
New England Journal of Medicine
↗ 3,927
OA
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sánchez-Vega, Marco Mina, Joshua Armenia, et al.
·
2018
·
Cell
↗ 3,319
OA
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence, Petar Stojanov, Craig H. Mermel, et al.
·
2014
·
Nature
↗ 3,165
OA
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Ross L. Levine, Martha Wadleigh, Jan Cools, et al.
·
2005
·
Cancer Cell
↗ 2,984
OA